n-3 fatty acids and breast cancer.
Bougnoux
P
P
INSERM EMI 02-11, Université François-Rabelais, Tours, France.
Maillard
V
V
Ferrari
P
P
Jourdan
M L
ML
Chajès
V
V
D000273:Adipose Tissue / Q000378:metabolism*; D000975:Antioxidants / Q000008:administration & dosage / Q000378:metabolism; D015415:Biomarkers / Q000737:chemistry; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000473:pathology / Q000517:prevention & control; D016022:Case-Control Studies; D016001:Confidence Intervals; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage* / Q000378:metabolism; D005260:Female; D006801:Humans; D015994:Incidence; D019787:Linoleic Acid / Q000378:metabolism; D016017:Odds Ratio; D012307:Risk Factors; D017962:alpha-Linolenic Acid / Q000378:metabolism
D000975:Antioxidants; D015415:Biomarkers; D015525:Fatty Acids, Omega-3; D017962:alpha-Linolenic Acid; D019787:Linoleic Acid